Related posts
Questrade Review: Pros & Cons of Trading with Questrade Canada (2023)Questrade vs Others | The Review Competitors Don’t Want you to Read (2023)Stockchase Panic-Proof Portfolio – May 2023 UpdateInmed Pharmaceuticals is a Canadian stock, trading under the symbol IN-T on the Toronto Stock Exchange (IN-CT). It is usually referred to as TSX:IN or IN-T
In the last year, there was no coverage of Inmed Pharmaceuticals published on Stockchase.
Inmed Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Inmed Pharmaceuticals.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Inmed Pharmaceuticals published on Stockchase.
On 2021-05-07, Inmed Pharmaceuticals (IN-T) stock closed at a price of $4.19.
This is another company in the cannabis space. This is not a cannabis producer, it is a company that adds value in that space. They are mapping cannabinoids, looking for different formulations to treat different diseases.It is highly speculative, but he thinks there is opportunity for this type of company. He likes the management. In a growth market, as the US opens up, this could do very well. He owns stocks like this in a basket. He is not betting on any one of them; instead he is expecting the overall basket to do well.